Trial Profile
Phase 4 Clinical Trial of Cervico-vaginal Immune Responses Following Three Right Deltoid or Right Thigh Intramuscular Immunisations With TicoVac (Tick Borne Encephalitis Virus [TBEV]) Vaccine in Adult Female Participants
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Pharmacodynamics
- 06 Aug 2013 Planned End Date changed from 1 Apr 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 05 Apr 2013 Planned end date changed from 1 Jul 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 11 Mar 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.